252 related articles for article (PubMed ID: 19039140)
21. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
22. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa).
Farah BL; Sinha RA; Wu Y; Singh BK; Lim A; Hirayama M; Landau DJ; Bay BH; Koeberl DD; Yen PM
Sci Rep; 2017 Mar; 7():44408. PubMed ID: 28317891
[TBL] [Abstract][Full Text] [Related]
23. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
[TBL] [Abstract][Full Text] [Related]
24. A detailed characterization of the adult mouse model of glycogen storage disease Ia.
Salganik SV; Weinstein DA; Shupe TD; Salganik M; Pintilie DG; Petersen BE
Lab Invest; 2009 Sep; 89(9):1032-42. PubMed ID: 19581879
[TBL] [Abstract][Full Text] [Related]
25. Regulation of liver metabolism by the endosomal GTPase Rab5.
Zeigerer A; Bogorad RL; Sharma K; Gilleron J; Seifert S; Sales S; Berndt N; Bulik S; Marsico G; D'Souza RCJ; Lakshmanaperumal N; Meganathan K; Natarajan K; Sachinidis A; Dahl A; Holzhütter HG; Shevchenko A; Mann M; Koteliansky V; Zerial M
Cell Rep; 2015 May; 11(6):884-892. PubMed ID: 25937276
[TBL] [Abstract][Full Text] [Related]
26. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Hiraiwa H; Pan CJ; Lin B; Akiyama TE; Gonzalez FJ; Chou JY
J Biol Chem; 2001 Mar; 276(11):7963-7. PubMed ID: 11121425
[TBL] [Abstract][Full Text] [Related]
27. Epithelial cells and Von Gierke's disease.
Negishi H; Benke PJ
Pediatr Res; 1977 Aug; 11(8):936-9. PubMed ID: 196249
[TBL] [Abstract][Full Text] [Related]
28. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
[No Abstract] [Full Text] [Related]
29. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Yavarow ZA; Kang HR; Waskowicz LR; Bay BH; Young SP; Yen PM; Koeberl DD
Hum Mol Genet; 2020 Jan; 29(2):286-294. PubMed ID: 31816064
[TBL] [Abstract][Full Text] [Related]
30. Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line.
Li X; Xu M; Wang F; Ji Y; DavidsoN WS; Li Z; Tso P
PLoS One; 2015; 10(11):e0142098. PubMed ID: 26556724
[TBL] [Abstract][Full Text] [Related]
31. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
[TBL] [Abstract][Full Text] [Related]
32. Diazoxide in von Gierke's disease.
Rennert OM; Mukhopadhyay D
Arch Dis Child; 1968 Jun; 43(229):358-61. PubMed ID: 5240134
[No Abstract] [Full Text] [Related]
33. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a.
Lei KJ; Shelly LL; Pan CJ; Sidbury JB; Chou JY
Science; 1993 Oct; 262(5133):580-3. PubMed ID: 8211187
[TBL] [Abstract][Full Text] [Related]
34. Preliminary studies of liver glucose-6-phosphatase in von Gierke's disease.
HARRIS RC
AMA Am J Dis Child; 1952 Nov; 84(5):627-8. PubMed ID: 12984830
[No Abstract] [Full Text] [Related]
35. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G
J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786
[TBL] [Abstract][Full Text] [Related]
36. Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
Saeed A; Hoogerland JA; Wessel H; Heegsma J; Derks TGJ; van der Veer E; Mithieux G; Rajas F; Oosterveer MH; Faber KN
Hum Mol Genet; 2020 Jan; 29(2):264-273. PubMed ID: 31813960
[TBL] [Abstract][Full Text] [Related]
37. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F
Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262
[TBL] [Abstract][Full Text] [Related]
38. Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats?
Azzout-Marniche D; Gaudichon C; Blouet C; Bos C; Mathé V; Huneau JF; Tomé D
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1400-7. PubMed ID: 17158265
[TBL] [Abstract][Full Text] [Related]
39. Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cells.
Cao J; Markel A; Hanahoe E; Ketova T; Mihai C; Zalinger Z; Marquardt D; Amato NJ; Cheng YM; Reid DW; Dousis A; Giangrande PH; Schultz JR; Martini PGV; Finn PF
Amino Acids; 2023 May; 55(5):695-708. PubMed ID: 36944899
[TBL] [Abstract][Full Text] [Related]
40. Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver.
Haase TN; Ringholm S; Leick L; Biensø RS; Kiilerich K; Johansen S; Nielsen MM; Wojtaszewski JF; Hidalgo J; Pedersen PA; Pilegaard H
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1501-9. PubMed ID: 21832205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
